DAIC

NOVEMBER 8, 2024

Centers for Medicare & Medicaid Services (CMS) have granted the company’s Paradise Ultrasound Renal Denervation system a Transitional Pass-through (TPT) payment. It becomes effective January 1, 2025, and is expected to remain effective for up to three years.

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

DAIC

MARCH 28, 2025

tim.hodson Fri, 03/28/2025 - 15:23 Mar. v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. Our introduction of Revolution Vibe underscores our commitment to this mission.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

DAIC

MARCH 27, 2025

tim.hodson Thu, 03/27/2025 - 15:40 March 27, 2025 GE HealthCare is announcing theU.S.launch of Flyrcado(flurpiridaz F 18) injection at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo inChicago. Flyrcado is aunit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

DAIC

JULY 29, 2024

Edwards has entered into an agreement to acquire JenaValve Technology , a pioneer in the transcatheter treatment of aortic regurgitation (AR), a deadly disease that impacts a significant and growing population and is largely untreated today. A CMS national coverage determination is expected in early 2025. billion.

Innovation 105

Innovation Aortic valve Aortic CMS 105

CardiacWire

JULY 28, 2024

Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments.

Heart Failure 59

Heart Failure Aortic TAVR Critical Care 59

DAIC

JANUARY 14, 2025

tim.hodson Tue, 01/14/2025 - 11:19 Jan. tim.hodson Tue, 01/14/2025 - 11:19 Jan. This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the SymplicitySpyral renal denervation (RDN) system, used in the Symplicity blood pressure procedure.

CMS 52

CMS Medicare Blood Pressure Medicaid 52

DAIC

JANUARY 27, 2025

tim.hodson Mon, 01/27/2025 - 09:47 Jan. tim.hodson Mon, 01/27/2025 - 09:47 Jan. This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the SymplicitySpyral renal denervation (RDN) system, used in the Symplicity blood pressure procedure.

CMS 52

CMS Blood Pressure Medicare Hypertension 52